Skip to content

THE STUDY OF VISUAL OUTCOME OF REFRACTIVE PROCEDURE USING LASER FOR THE TREATMENT OF SHORT SIGHTEDNESS

THE STUDY OF EFFICACY AND SAFETY OF REFRACTIVE LENTICULAR EXTRACTION (RELEX)- SMILE PROCEDURE USING FEMTOSECOND LASER.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/10/005101
Enrollment
50
Registered
2014-10-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- SHORT SIGHTEDNESS

Interventions

Intervention1: RELEX SMILE PROCEDURE: RELEX SMILE PROCEDURE IS A FLAPLESS, ALL FEMTO & SINGLE STEP â?? CORNEAL REFRACTIVE SURGERY WHEREIN A LENTICULE-A DISC OF CORNEAL TISSUE IS CUT WITH A MICRON SCA

Sponsors

NETHRADHAMA SUPERSPECIALITY EYE HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: •Patients within the age limit 21- 40 years. •Patients with myopia ( •Stability of refractive error at least for the previous 1 year. •Patients have to discontinue soft contact lens for minimum 1 week and rigid gas permeable contact lens for minimum 2- 3 weeks before the baseline measurement.

Exclusion criteria

Exclusion criteria: •Patientâ??s age less than 21 years and more than 40 years. •Evidence of lid diseases like meibomian gland dysfunction. •Anterior segment pathologies of the cornea like corneal dystrophy, corneal scars, topographic evidence of keratoconus, residual/recurrent/active ocular disease such as uveitis, severe dry eyes, severe allergic eye disease, glaucoma, visually significant cataract. •Retinal pathologies like diabetic retinopathy and retinal dystrophies. •Progressive or unstable myopia and or astigmatism. •History of herpetic keratitis or other forms of keratitis. •Previous intraocular or corneal surgery. •Ocular medications being used like anti-glaucoma medications. •Systemically immunocompromised. •Pregnant or nursing women.

Design outcomes

Primary

MeasureTime frame
â?¢Visual and refractive outcomes, efficacy and safety index including quality of vision. â?¢Contrast sensitivity. â?¢Dry eye assessment. â?¢Postoperative pain. â?¢Glare. Timepoint: PRE OPERATIVE,POST OPERATIVE DAY 1,DAY 2, AND DAY 90

Secondary

MeasureTime frame
Residual refractive errorTimepoint: 6 mths

Countries

India

Contacts

Public ContactDR SRI GANESH

NETHRADHAMA SUPERSPECIALITY EYE HOSPITAL

drsunilkumar24@gmail.com9901654949

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026